Aarey Drugs & Pharmaceuticals Limited

NSE: AAREYDRUGS

23

total announcements

AAREYDRUGS.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 21 Oct 2026

Market Cap

₹363 Cr

P/E (TTM)

77.5

EPS (TTM)

₹1.47

52W Low

₹50.31

52W High

₹114.80

Dividend Yield

0.00%

Beta

1.24

Price / Book

2.2

Debt / Equity

40.4

Revenue (TTM)

₹415 Cr

Gross Margin

3.82%

Operating Margin

1.07%

NSEDisclosure under SEBI Takeover RegulationsRegulatory6 Jul 2026

Aarey Drugs & Pharmaceuticals Limited

Disclosure under SEBI Takeover Regulations

Aarey Drugs & Pharmaceuticals Limited has submitted a disclosure under SEBI Takeover Regulations, indicating a potential takeover or acquisition activity.

Read more →📎 1 attachment
NSEDisclosure under SEBI Takeover RegulationsRegulatory1 Jul 2026

Aarey Drugs & Pharmaceuticals Limited

Disclosure under SEBI Takeover Regulations

Aarey Drugs & Pharmaceuticals Limited has submitted a disclosure under SEBI Takeover Regulations, as per Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Read more →📎 1 attachment
NSETrading Window26 Jun 2026

Aarey Drugs & Pharmaceuticals Limited

Trading Window

Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Read more →📎 1 attachment
← PreviousPage 2 of 2